Tissue Regenix Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	21	43	37	40	38	38	Upgrade
Market Cap Growth	16.73%	16.73%	-7.68%	5.65%	-0.93%	227.82%	Upgrade
Enterprise Value	27	48	40	41	36	27	Upgrade
Last Close Price	0.29	0.60	0.52	0.56	0.54	0.54	Upgrade
Forward PE	-	250.00	-	-	-	-	Upgrade
PS Ratio	0.92	1.87	1.58	1.95	2.57	3.14	Upgrade
PB Ratio	0.91	1.84	1.59	1.57	1.52	1.35	Upgrade
P/TBV Ratio	1.87	3.81	2.75	2.72	2.53	2.15	Upgrade
P/FCF Ratio	-	-	74.38	-	-	-	Upgrade
P/OCF Ratio	-	-	44.85	-	-	-	Upgrade
EV/Sales Ratio	1.19	2.09	1.74	2.01	2.45	2.21	Upgrade
EV/EBITDA Ratio	24.47	46.40	113.67	-	-	-	Upgrade
EV/EBIT Ratio	97.82	171.24	-	-	-	-	Upgrade
EV/FCF Ratio	-6.92	-	81.76	-	-	-	Upgrade
Debt / Equity Ratio	0.36	0.36	0.32	0.32	0.24	0.19	Upgrade
Debt / EBITDA Ratio	7.50	7.50	16.11	-	-	-	Upgrade
Debt / FCF Ratio	-	-	14.98	-	-	-	Upgrade
Asset Turnover	0.65	0.65	0.66	0.53	0.41	0.36	Upgrade
Inventory Turnover	1.23	1.23	1.46	1.28	1.17	1.16	Upgrade
Quick Ratio	1.08	1.08	1.72	1.59	2.59	3.76	Upgrade
Current Ratio	3.46	3.46	4.03	3.32	5.06	6.16	Upgrade
Return on Equity (ROE)	-2.92%	-2.92%	-5.55%	-8.14%	-13.91%	-34.70%	Upgrade
Return on Assets (ROA)	0.49%	0.49%	-0.55%	-2.72%	-5.21%	-5.84%	Upgrade
Return on Capital (ROIC)	0.56%	0.56%	-0.63%	-3.09%	-5.79%	-6.54%	Upgrade
Return on Capital Employed (ROCE)	0.90%	0.90%	-	-	-	-	Upgrade
Earnings Yield	-2.71%	-1.33%	-3.67%	-5.64%	-9.43%	-24.10%	Upgrade
FCF Yield	-18.75%	-9.22%	1.34%	-3.50%	-8.90%	-14.74%	Upgrade
Buyback Yield / Dilution	-5.46%	-5.46%	-0.12%	-0.02%	-58.13%	-279.54%	Upgrade

Updated Sep 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.